title: Late cyclosporine conversion carries risk of irreversible rejection.
authors.affiliation: UTSMCD/Division of Urology, TX 75235.
authors.forename: A I
authors.initials: AI
authors.lastname: Sagalowsky
authors.forename: M E
authors.initials: ME
authors.lastname: Reisman
authors.forename: I
authors.initials: I
authors.lastname: Dawidson
authors.forename: R
authors.initials: R
authors.lastname: Toto
authors.forename: P C
authors.initials: PC
authors.lastname: Peters
authors.forename: J H
authors.initials: JH
authors.lastname: Helderman
mesh_terms: D001379:Azathioprine / Q000008:administration & dosage*; D002102:Cadaver; D003524:Cyclosporins / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007674:Kidney Diseases / Q000139:chemically induced; D016030:Kidney Transplantation
chemical_list: D003524:Cyclosporins; D001379:Azathioprine